1 |
Couet J, Li S, Okamoto T, Ikezu T and Lisanti MP (1997) Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem 272, 6525-6533
DOI
ScienceOn
|
2 |
Razani B, Woodman SE and Lisanti MP (2002) Caveolae: from cell biology to animal physiology. Pharmacol Rev 54, 431-467
DOI
ScienceOn
|
3 |
Merritt R, Hayman MJ and Agazie YM (2006) Mutation of Thr466 in SHP2 abolishes its phosphatase activity, but provides a new substrate-trapping mutant. Biochim Biophys Acta 1763, 45-56
DOI
ScienceOn
|
4 |
Agazie YM and Hayman MJ (2003) Development of an efficient "substrate-trapping" mutant of Src homology phosphotyrosine phosphatase 2 and identification of the epidermal growth factor receptor, Gab1, and three other proteins as target substrates. J Biol Chem 278, 13952-13958
DOI
ScienceOn
|
5 |
Poole AW and Jones ML (2005) A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail. Cell Signal 17, 1323-1332
DOI
ScienceOn
|
6 |
Salmond RJ and Alexander DR (2006) SHP2 forecast for the immune system: fog gradually clearing. Trends Immunol 27, 154-160
DOI
ScienceOn
|
7 |
Tiffany-Castiglioni E, Hong S and Qian Y (2011) Copper handling by astrocytes: insights into neurodegenerative diseases. Int J Dev Neurosci 29, 811-818
DOI
ScienceOn
|
8 |
Gee CE and Mansuy IM (2005) Protein phosphatases and their potential implications in neuroprotective processes. Cell Mol Life Sci 62, 1120-1130
DOI
|
9 |
Yun JH, Park SJ, Jo A et al (2011) Caveolin-1 is involved in reactive oxygen species-induced SHP-2 activation in astrocytes. Exp Mol Med 43, 660-668
DOI
ScienceOn
|
10 |
Jo A, Park H, Lee SH et al (2014) SHP-2 binds to caveolin-1 and regulates Src activity via competitive inhibition of CSK in response to H2O2 in astrocytes. PLoS One 9, e91582
DOI
|
11 |
Neel BG, Gu H and Pao L (2003) The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 28, 284-293
DOI
ScienceOn
|
12 |
Kim HY, Park SJ, Joe EH and Jou I (2006) Raft-mediated Src homology 2 domain-containing proteintyrosine phosphatase 2 (SHP-2) regulation in microglia. J Biol Chem 281, 11872-11878
DOI
ScienceOn
|
13 |
Lacalle RA, Mira E, Gomez-Mouton C, Jimenez-Baranda S, Martinez AC and Manes S (2002) Specific SHP-2 partitioning in raft domains triggers integrin-mediated signaling via Rho activation. J Cell Biol 157, 277-289
DOI
ScienceOn
|
14 |
Pluskota E, Chen Y and D'Souza SE (2000) Src homology domain 2-containing tyrosine phosphatase 2 associates with intercellular adhesion molecule 1 to regulate cell survival. J Biol Chem 275, 30029-30036
DOI
ScienceOn
|
15 |
Kim BW, Lee CS, Yi JS et al (2010) Lipid raft proteome reveals that oxidative phosphorylation system is associated with the plasma membrane. Expert Rev Proteomics 7, 849-866
DOI
ScienceOn
|
16 |
Emerit J, Edeas M and Bricaire F (2004) Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 58, 39-46
DOI
ScienceOn
|
17 |
Reynolds A, Laurie C, Mosley RL and Gendelman HE (2007) Oxidative stress and the pathogenesis of neurodegenerative disorders. Int Rev Neurobiol 82, 297-325
DOI
ScienceOn
|
18 |
Groeger G, Quiney C and Cotter TG (2009) Hydrogen peroxide as a cell-survival signaling molecule. Antioxid Redox Signal 11, 2655-2671
DOI
|
19 |
Hirrlinger J and Dringen R (2010) The cytosolic redox state of astrocytes: Maintenance, regulation and functional implications for metabolite trafficking. Brain Res Rev 63, 177-188
DOI
ScienceOn
|
20 |
Uttara B, Singh AV, Zamboni P and Mahajan RT (2009) Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 7, 65-74
DOI
ScienceOn
|
21 |
Park SJ, Lee JH, Kim HY et al (2012) Astrocytes, but not microglia, rapidly sense H(2)O(2)via STAT6 phosphorylation, resulting in cyclooxygenase-2 expression and prostaglandin release. J Immunol 188, 5132-5141
DOI
ScienceOn
|
22 |
Parpura V, Heneka MT, Montana V et al (2012) Glial cells in (patho)physiology. J Neurochem 121, 4-27
DOI
ScienceOn
|
23 |
Cai T, Nishida K, Hirano T and Khavari PA (2002) Gab1 and SHP-2 promote Ras/MAPK regulation of epidermal growth and differentiation. J Cell Biol 159, 103-112
DOI
ScienceOn
|
24 |
Suzuki T, Matozaki T, Mizoguchi A and Kasuga M (1995) Localization and subcellular distribution of SH-PTP2, a protein-tyrosine phosphatase with Src homology-2 domains, in rat brain. Biochem Biophys Res Commun 211, 950-959
DOI
ScienceOn
|
25 |
You M, Yu DH and Feng GS (1999) Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway. Mol Cell Biol 19, 2416-2424
DOI
|
26 |
Arnaud M, Mzali R, Gesbert F et al (2004) Interaction of the tyrosine phosphatase SHP-2 with Gab2 regulates Rho-dependent activation of the c-fos serum response element by interleukin-2. Biochem J 382, 545-556
DOI
ScienceOn
|
27 |
Goetz JG, Lajoie P, Wiseman SM and Nabi IR (2008) Caveolin-1 in tumor progression: the good, the bad and the ugly. Cancer Metastasis Rev 27, 715-735
DOI
|
28 |
Cao H, Courchesne WE and Mastick CC (2002) A phosphotyrosine-dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14: recruitment of C-terminal Src kinase. J Biol Chem 277, 8771-8774
DOI
ScienceOn
|